Moreover, in RA patients, CD21low B cells might have a role in joint damage via bone erosion by secreting the receptor activator of nuclear factor kappa-B ligand (RANKL) and IL-6 [12]. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.